CareDx (CDNA) Tops Q4 EPS by 26c; Offers FY23 Revenue Guidance

CareDx (NASDAQ: CDNA) reported Q4 EPS of ($0.07), $0.26 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $82.4 million versus the consensus estimate of $81.67 million.

GUIDANCE:

CareDx sees FY2023 revenue of $328-338 million, versus the consensus of $321 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge
• AeroVironment restates quarterly financials, citing $89M goodwill error